Ribavirin

interleukin 10 ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28391873 IL-10 and IL-28B gene variants as predictors of sustained response to peginterferon and ribavirin therapy in chronic HCV infection. 2022 Mar 1
2 27793650 Interleukin 10 gene single nucleotide polymorphisms in Polish patients with chronic hepatitis C: Analysis of association with severity of disease and treatment outcome. 2017 Feb 1
3 27543394 Influence of IL10 Gene polymorphisms on the sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy. 2016 Nov 2
4 24641916 Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy. 2015 Jan 6
5 26557951 Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance. 2015 Nov 8 1
6 24994464 Low IL10 serum levels as key factor for predicting the sustained virological response to IFNα/ribavirin in Brazilian patients with HCV carrying IL28B CT/TT genotype. 2014 Aug 1
7 25393884 Ribavirin shows immunomodulatory effects on activated microglia. 2014 Dec 1
8 21871023 Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin-10 secretion to assist in hepatitis C virus clearance. 2012 Apr 8
9 22848715 Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C. 2012 1
10 22891772 Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell. 2012 Nov 2
11 23020144 Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy. 2012 Dec 1
12 21398397 Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients. 2011 Apr 15 1
13 21567425 Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy. 2011 Jul 1
14 22024523 Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C. 2011 1
15 19555400 Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection. 2009 Oct 2
16 18619701 DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. 2008 Oct 1
17 16611188 Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. 2006 Apr 1
18 15328100 Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. 2004 Sep 2
19 15505595 Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production). 2004 Jul-Sep 1
20 11830340 Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. 2002 Feb 1
21 10648463 Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. 2000 Feb 2
22 10190717 Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. 1999 Mar 1
23 9722937 Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. 1998 Aug 1